NPPA issued a notification regarding the fixation of retail price of Telmisartan IP 40 mg + Cilnidipine IP 10 mg + Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg (As extended-release form) for M/s Mascot Health Series Pvt. Ltd. (Manufacturer) & M/s Intas Pharmaceuticals Ltd. (Marketer)

Mar 04, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 03, 2026, issued a notification regarding the fixation of retail price of Telmisartan IP 40 mg + Cilnidipine IP 10 mg + Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg (As extended-release form) for M/s Mascot Health Series Pvt. Ltd. (Manufacturer) & M/s Intas Pharmaceuticals Ltd. (Marketer).

The following has been stated: -

•For each film-coated bilayer tablet contains: Telmisartan IP 40 mg + Cilnidipine IP 10 mg + Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg (As extended-release form) for M/s Mascot Health Series Pvt. Ltd. (Manufacturer) & M/s Intas Pharmaceuticals Ltd. (Marketer), the retail price is 11.77 (Rs).

The detailed notification is given in the document below.

[Notification No.: 19(5054)/2026/DP/NPPA/Div.III/13287/2026]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT